EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Heated humidified high flow nasal cannula therapy in children with obstructive sleep apnea: A randomized cross-over trial

Haley Fishman, Nawal Al-Shamli, Kanokkarn Sunkonkit, Bryan Maguire, Sarah Selvadurai, Adele Baker, Reshma Amin, Evan J Propst, Nikolaus E Wolter, Danny J Eckert, Eyal Cohen, Indra Narang

Sleep Medicine · 2023

DOI: 10.1016/j.sleep.2023.04.017 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Sleep Medicine, 2023. Verfasst von Haley Fishman und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Division of Respiratory Medicine, Department of Pediatrics, The Hospital for Sick Children, 4539 Hill Wing, 555 University Avenue, Toronto, Ontar…. Hauptthemen laut MEDLINE: Cannula, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE/BACKGROUND: Moderate-to-severe obstructive sleep apnea (OSA) is highly prevalent in children with obesity and/or underlying medical complexity. The first line of therapy, adenotonsillectomy (AT), does not cure OSA in more than 50% of these children. Consequently, continuous positive airway pressure (CPAP) is the main therapeutic option but adherence is often poor. A potential alternative which may be associated with greater adherence is heated high-flow nasal cannula (HFNC) therapy; however, its efficacy in children with OSA has not been systematically investigated. The study aimed to compare the efficacy of HFNC with CPAP to treat moderate-to-severe OSA with the primary outcome measuring the change from baseline in the mean obstructive apnea/hypopnea index (OAHI). PARTICIPANTS/METHODS: This was a single-blinded randomized, two period crossover trial conducted from March 2019 to December 2021 at a Canadian pediatric quaternary care hospital. Children aged 2-18 years with obesity and medical complexity diagnosed with moderate-to-severe OSA via overnight polysomnography and recommended CPAP therapy were included in the study. Following diagnostic polysomnography, each participant completed two further sleep studies; a HFNC titration study and a CPAP titration study (9 received HFNC first, and 9 received CPAP first) in a random 1:1 allocation order. RESULTS: Eighteen participants with a mean ± SD age of 11.9 ± 3.8 years and OAHI 23.1 ± 21.7 events/hour completed the study. The mean [95% CI] reductions in OAHI (-19.8[-29.2, -10.5] vs. -18.8 [-28.2, -9.4] events/hour, p = 0.9), nadir oxygen saturation (7.1[2.2, 11.9] vs. 8.4[3.5, 13.2], p = 0.8), oxygen desaturation index (-11.6[-21.0, -2.3] vs. -16.0[-25.3, -6.6], p = 0.5) and sleep efficiency (3.5[-4.8, 11.8] vs. 9.2[0.9, 15.5], p = 0.2) with HFNC and CPAP therapy were comparable between conditions. CONCLUSION: HFNC and CPAP therapy yield similar reductions in polysomnography quantified measures of OSA severity among children with obesity and medical complexities. TRIAL REGISTRATION: NCT05354401 ClinicalTrials.gov.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannulaSleep Apnea, ObstructiveHumansChildCross-Over StudiesCanadaContinuous Positive Airway PressureObesity

Stichwörter der Autor:innen

Continuous positive airway pressureHigh-flow nasal cannulaObstructive sleep apneaPediatric

Autor:innen und Institutionen

  • The Division of Respiratory Medicine, Department of Pediatrics, The Hospital for Sick Children, 4539 Hill Wing, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada; The University of Toronto, Toronto, Ontario, Cana…
  • Division of Respiratory Medicine, Department of Pediatrics, Sultan Qaboos University, Muscat 123, Oman.
  • Division of Pulmonary and Critical Care, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada.
  • Department of Otolaryngology-Head and Neck Surgery, The Hospital for Sick Kids, Toronto, Ontario, Canada; The University of Toronto, Toronto, Ontario, Canada.
  • Flinders Health and Medical Research Institute and Adelaide Institute for Sleep Health, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Zitieren

APA

Fishman, H., Al-Shamli, N., Sunkonkit, K., Maguire, B., Selvadurai, S., Baker, A., Amin, R., Propst, E. J., Wolter, N. E., Eckert, D. J., Cohen, E., & Narang, I. (2023). Heated humidified high flow nasal cannula therapy in children with obstructive sleep apnea: A randomized cross-over trial. Sleep Medicine. https://doi.org/10.1016/j.sleep.2023.04.017

Vancouver

Fishman H, Al-Shamli N, Sunkonkit K, Maguire B, Selvadurai S, Baker A, et al. Heated humidified high flow nasal cannula therapy in children with obstructive sleep apnea: A randomized cross-over trial. Sleep Medicine. 2023. doi:10.1016/j.sleep.2023.04.017

BibTeX
@article{Fishman2023,
  author = {Fishman, Haley and Al-Shamli, Nawal and Sunkonkit, Kanokkarn and Maguire, Bryan and Selvadurai, Sarah and Baker, Adele and Amin, Reshma and Propst, Evan J and Wolter, Nikolaus E and Eckert, Danny J and Cohen, Eyal and Narang, Indra},
  title = {Heated humidified high flow nasal cannula therapy in children with obstructive sleep apnea: A randomized cross-over trial},
  journal = {Sleep Medicine},
  year = {2023},
  doi = {10.1016/j.sleep.2023.04.017}
}
Kostenlos starten →